PCK1 and pancreatic neoplasm: In pancreatic cancer cells, shRNA-induced PCK1 silencing or CRISPR/Cas9-induced PCK1 KO robustly inhibited cell growth, viability, proliferation, migration and invasion, and provoked apoptosis activation.